NanoViricides, Inc. reported earnings results for the full year ended June 30, 2023. For the full year, the company reported net loss was USD 8.59 million compared to USD 8.11 million a year ago. Basic loss per share from continuing operations was USD 0.74 compared to USD 0.7 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.15 USD | -4.17% | 0.00% | +12.75% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.75% | 14.13M | |
-0.42% | 102B | |
+3.72% | 96.09B | |
+2.13% | 22.28B | |
-14.65% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.18% | 16.09B | |
+9.89% | 13.83B | |
+35.13% | 11.97B |
- Stock Market
- Equities
- NNVC Stock
- News NanoViricides, Inc.
- NanoViricides, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023